Product NDC: | 0703-2812 |
Proprietary Name: | Pancuronium Bromide |
Non Proprietary Name: | Pancuronium Bromide |
Active Ingredient(s): | 2 mg/mL & nbsp; Pancuronium Bromide |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0703-2812 |
Labeler Name: | Teva Parenteral Medicines, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA072760 |
Marketing Category: | ANDA |
Start Marketing Date: | 19900801 |
Package NDC: | 0703-2812-04 |
Package Description: | 25 VIAL in 1 TRAY (0703-2812-04) > 2 mL in 1 VIAL (0703-2812-01) |
NDC Code | 0703-2812-04 |
Proprietary Name | Pancuronium Bromide |
Package Description | 25 VIAL in 1 TRAY (0703-2812-04) > 2 mL in 1 VIAL (0703-2812-01) |
Product NDC | 0703-2812 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Pancuronium Bromide |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19900801 |
Marketing Category Name | ANDA |
Labeler Name | Teva Parenteral Medicines, Inc. |
Substance Name | PANCURONIUM BROMIDE |
Strength Number | 2 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Neuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC] |